BioNTech: From Pandemic Powerhouse to Trailblazer in Cancer Research
BioNTech transitions from COVID-19 vaccine success to focus on mRNA-based cancer therapies, facing challenges and opportunities. Financial performance reveals a downturn, with quarterly earnings and revenue experiencing notable declines but…